SummaryRMgm-5029
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 34119684 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | Not applicable |
Other information parent line | |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | Yuda M, Nishi T |
Name Group/Department | Department of Medical Zoology |
Name Institute | Mie University School of Medicine |
City | Mie, Tsu |
Country | Japan |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-5029 |
Principal name | AP2-G-GFP |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Fluorescent signals, indicating AP2-G expression, were detected only in a very small number of mononuclear parasites by fluorescence microscopy (one parasite per dozens of fields by microscopic scrutiny). We assumed that they were early gametocytes and that their number appeared very small, as AP2-G is expressed only in a limited period of gametocyte development. In synchronized infections: In mature schizonts prior to inoculation, AP2-G expression was not observed. At 12 h post-inoculation (hpi), weak signals were first observed in a small number of parasites. Signals of AP2-G and the pro-portion of AP2-G-expressing parasites increased gradually thereafter (the proportion at 14 hpi was approximately 2%) and then reached the peak at 16 to 18 hpi, when morphological divergence between early gametocytes and asexual parasites began. The proportion of AP2-G- expressing parasites was approximately 4% at this peak. Then, fluorescent signals decreased gradually, and at 20 to 22 hpi, when sex-specific morphologies were manifested on them, signals decreased to the level where AP2-G was only slightly observed in the nucleus |
Gametocyte/Gamete | Fluorescent signals, indicating AP2-G expression, were detected only in a very small number of mononuclear parasites by fluorescence microscopy (one parasite per dozens of fields by microscopic scrutiny). We assumed that they were early gametocytes and that their number appeared very small, as AP2-G is expressed only in a limited period of gametocyte development. In synchronized infections: In mature schizonts prior to inoculation, AP2-G expression was not observed. At 12 h post-inoculation (hpi), weak signals were first observed in a small number of parasites. Signals of AP2-G and the pro-portion of AP2-G-expressing parasites increased gradually thereafter (the proportion at 14 hpi was approximately 2%) and then reached the peak at 16 to 18 hpi, when morphological divergence between early gametocytes and asexual parasites began. The proportion of AP2-G- expressing parasites was approximately 4% at this peak. Then, fluorescent signals decreased gradually, and at 20 to 22 hpi, when sex-specific morphologies were manifested on them, signals decreased to the level where AP2-G was only slightly observed in the nucleus |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation In synchronized infections: In mature schizonts prior to inoculation, AP2-G expression was not observed. At 12 h post-inoculation (hpi), weak signals were first observed in a small number of parasites. Signals of AP2-G and the pro-portion of AP2-G-expressing parasites increased gradually thereafter (the proportion at 14 hpi was approximately 2%) and then reached the peak at 16 to 18 hpi, when morphological divergence between early gametocytes and asexual parasites began. The proportion of AP2-G- expressing parasites was approximately 4% at this peak. Then, fluorescent signals decreased gradually, and at 20 to 22 hpi, when sex-specific morphologies were manifested on them, signals decreased to the level where AP2-G was only slightly observed in the nucleus Additional information From the Abstract: Other mutants |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1437500 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1222600 | ||||||||||||||||||||||||||
Gene product | AP2 domain transcription factor AP2-G | ||||||||||||||||||||||||||
Gene product: Alternative name | AP2-G; ApiAP2 | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | EGFP | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | (Linear) plasmid double cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | unknown | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | |||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |